Bayer AG· @Bayer · X·· 14 天前AI 评分40
AI 导读
制药业务驱动增长:拜耳在2026年第三季度实现销售额与特殊项目前EBITDA增长,并上调全年业绩展望 我们的数字化季度报告:https://spr.ly/6014BHa1ka
正文
Pharmaceuticals drives growth: Bayer increases sales and EBITDA before special items in third quarter of 2026, improves full-year outlook
Here's our digital quarterly statement: https://spr.ly/6014BHa1ka
来源:Bayer AG · x.com